[1]
M. Čarapić, K. Nikolić, and D. Agbaba, “Genotoxic impurities in medicinal products – regulatory requirements”, arhfarm, vol. 72, no. Suppl. 4, pp. S133–134, Oct. 2022, Accessed: Jul. 12, 2026. [Online]. Available: https://asistent.ceon.rs/index.php/arhfarm/article/view/38531